STOCK TITAN

LeMaitre Vascular to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) announced its participation in two upcoming investor conferences in January 2021. CFO JJ Pellegrino will present at the 23rd Annual Needham Virtual Growth Conference on January 11, 2021, at 11:30 AM ET, and at the Sidoti Winter 2021 Investor Conference on January 14, 2021, at 10:45 AM ET. The company, which specializes in devices for treating peripheral vascular disease, aims to inform and engage investors about its market position and growth strategies.

Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., Dec. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in January.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the 23rd Annual Needham Virtual Growth Conference on Monday, January 11, 2021, at 11:30 AM ET.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Sidoti Winter 2021 Investor Conference on Thursday, January 14, 2021, at 10:45 AM ET.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.


FAQ

What conferences is LeMaitre Vascular participating in January 2021?

LeMaitre Vascular is participating in the 23rd Annual Needham Virtual Growth Conference on January 11, 2021, and the Sidoti Winter 2021 Investor Conference on January 14, 2021.

Who is presenting for LeMaitre Vascular at these conferences?

CFO JJ Pellegrino will present for LeMaitre Vascular at both conferences.

What is the purpose of LeMaitre Vascular's participation in these investor conferences?

The participation aims to engage investors and provide insights into the company's market position and growth strategies.

What is LeMaitre Vascular known for?

LeMaitre Vascular is known for providing devices, implants, and services for the treatment of peripheral vascular disease.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects more than 200 million people worldwide.

LeMaitre Vascular, Inc.

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Stock Data

2.41B
20.50M
8.84%
94.18%
3.49%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
BURLINGTON